It has been previously reported that manipulation of MeCP2 influences neurotransmitter systems, such as GABA [60], dopamine, and dopamine receptors, especially dopamine D2 receptor, in several brain regions which are associated with psychiatric disorders [33,34]. Here, DRD2 is linked to psychiatric disorder.